Terug

Watch Compare

CARLSMED, INC.

Datakwaliteit: 83%

CARL

Nasdaq Manufacturing Measuring & Analyzing Instruments

€ 9,65

▼ € 0,35 (-3,45%)

Marktkapitalisatie: 257,96 M

Prijs

€ 9,65

Marktkapitalisatie

257,96 M

Dagbereik

€ 9,51 — € 9,82

52-Weeksbereik

€ 8,87 — € 17,19

Volume

21.269

Openen € 9,59

50D / 200D Gem.

€ 11,70

17,51% below

50D / 200D Gem.

€ 12,93

25,35% below

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,14 — conservative balance sheet

Negative free cash flow of -29,62 M

Groei

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Kwaliteit

Return on Equity

-251,27%

Onder sectorgemiddelde (-51,02%)

ROIC-28,80%

Net MarginN/A

Op. MarginN/A

Veiligheid

Debt / Equity

0,14

Onder sectorgemiddelde (0,33)

Current Ratio12,03

Interest Coverage-21,38

Waardering

PE (TTM)

-8,70

Onder sectorgemiddelde (-1,98)

P/B Ratio2,42

EV/EBITDAN/A

Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)

Metriek	Aandeel	Sector Mediaan
P/E	-8,7	-2,0
P/B	2,4	5,1
ROE %	-251,3	-51,0
Net Margin %	—	-150,2
Rev Growth 5Y %	—	9,3
D/E	0,1	0,3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	-29,63 M
ROE	-251,27%	ROA	-31,50%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-29,62 M
ROIC	-28,80%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0,14	Current Ratio	12,03
Interest Coverage	-21,38	Asset Turnover	N/A
Working Capital	120,54 M	Tangible Book Value	106,66 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-8,70	Forward P/E	N/A
P/B Ratio	2,42	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-11,48%
Market Cap	257,96 M	Enterprise Value	158,03 M
Per Share
EPS (Diluted TTM)	-2,12	Revenue / Share	N/A
FCF / Share	-1,11	OCF / Share	-1,08
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	99,95%
SBC-Adj. FCF	-31,55 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025
Revenue	—
Net Income	-29,63 M
EPS (Diluted)	-2,12
Gross Profit	38,04 M
Operating Income	-30,57 M
EBITDA	—
R&D Expenses	17,02 M
SG&A Expenses	—
D&A	281.000,0
Interest Expense	1,43 M
Income Tax	0,0

Balance Sheet

Annual, most recent first

Metric	FY2025
Total Assets	130,12 M
Total Liabilities	31,25 M
Shareholders' Equity	98,87 M
Total Debt	15,35 M
Cash & Equivalents	85,79 M
Current Assets	126,67 M
Current Liabilities	14,28 M